SoftBank Vision Fund Entities Sell Shares in Vir Biotechnology

SVF Endurance (Cayman) Ltd, SoftBank Vision Fund (AIV M1) L.P., and SB Investment Advisers (UK) Ltd, all ten percent owners of Vir Biotechnology, Inc., have sold shares of common stock. On October 22, 2025, SVF Endurance sold 144,266 shares at a weighted average price of $6.1529, reducing its holdings to 14,866,018 shares. On October 23, 2025, an additional 154,383 shares were sold at a weighted average price of $5.9898, bringing the total holdings to 14,711,635 shares. These transactions were executed under a Rule 10b5-1 trading plan established on September 3, 2025. The sales were conducted in multiple transactions within specified price ranges.